Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
Nightstar Therapeutics (NITE)

Organization & Developments: Nightstar

Parents

2017: Nightstar Therapeutics - Novel Gene Therapy Company And Recent IPO_seekingalpha
2018: Nightstar Therapeutics: Keep Your Eyes Peeled For September Catalysts - Nightstar Therapeutics plc (NASDAQ:NITE)
2018: Nightstar’s drug for rare vision loss admitted to FDA’s gene therapy speedway – Endpoints News
Nightstar Therapeutics is a clinical-stage biotechnology company developing gene therapies for the treatment of currently untreatable retinal diseases.